Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
The Lancet. Infectious Diseases|November 29, 2024
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic reviewWilliam Burman, Pauline Luczynski, C Robert Horsburgh, et al.
American Journal of Respiratory and Critical Care Medicine|May 20, 2006
Lack of weight gain and relapse risk in a large tuberculosis treatment trialAwal Khan, Timothy R Sterling, Randall Reves, et al.
Plos Medicine|July 25, 2024
Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approachWilliam Burman, Oxana Rucsineanu, C Robert Horsburgh, et al.
Controlled Clinical Trials|May 22, 2003
The effects of local review on informed consent documents from a multicenter clinical trials consortiumWilliam Burman, Peter Breese, Stephen Weis, et al.
Contemporary Clinical Trials|November 17, 2006
Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22)Donna Sepulveda Conwell, Ann Mosher, Awal Khan, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 5, 2014
TuberculosisC Robert Horsburgh
American Journal of Epidemiology|May 24, 2023
Invited Commentary: The Winding Road to Identifying the Annual Rate of Tuberculosis InfectionC Robert Horsburgh
The New England Journal of Medicine|May 14, 2004
Priorities for the treatment of latent tuberculosis infection in the United StatesC Robert Horsburgh
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2005
Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosisMarc Weiner, Debra Benator, Charles A Peloquin, et al.
Plos Medicine|September 16, 2009
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysisDick Menzies, Andrea Benedetti, Anita Paydar, et al.
Pageof 25